Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar-Apr:14:101001.
doi: 10.1016/j.cegh.2022.101001. Epub 2022 Mar 7.

COVID-19 vaccine acceptance and its associated factors in Ethiopia: A systematic review and meta-analysis

Affiliations
Review

COVID-19 vaccine acceptance and its associated factors in Ethiopia: A systematic review and meta-analysis

Birye Dessalegn Mekonnen et al. Clin Epidemiol Glob Health. 2022 Mar-Apr.

Abstract

Background: COVID-19 vaccination is considered as an effective intervention for controlling the burden of the pandemic. However, vaccine hesitation is increasing and hindering efforts targeting to reduce the burden of the COVID-19 disease. Hence, determining COVID-19 vaccine acceptance and identifying determinants that would hinder people to vaccinate against COVID-19 is crucial to effectively improve COVID-19 vaccine uptake. In Ethiopia, the pooled proportion of COVID-19 vaccine acceptance and its determinants is not well known. Thus, the aim of this study is to estimate the pooled proportion of COVID-19 vaccine acceptance and its determinants in Ethiopia.

Methods: A systematic search of articles was conducted from PubMed, Scopus, Web of Science, MEDLINE, CINAHL, Science Direct and Cochrane Library. Data were extracted using a data extraction tool which was adapted from the Joanna Briggs Institute. The quality of each included primary studies was evaluated using the Newcastle-Ottawa scale tool. Data analysis was performed using STATA 14. Heterogeneity in studies was assessed using Cochrane Q and I2 test. Publication bias was assessed using visual inspection of funnel plots and Egger's test. A random effects model was applied to determine the pooled estimates if heterogeneity was exhibited; otherwise, a fixed-effects model was used.

Results: A total of 14 studies involving 6373 participants were included for the final analysis. The pooled proportion of COVID-19 vaccine acceptance in Ethiopia was 56.02% (95% CI: 47.84, 64.20). The likelihood of COVID-19 vaccine acceptance was higher among participants who had history of chronic disease (AOR = 1.33, 95% CI: 1.09, 2.97), good knowledge (AOR = 2.13, 95% CI: 1.59, 4.97), positive attitude (AOR = 2.23, 95% CI: 1.21, 4.66), good COVID-19 preventive practice (AOR = 1.97, 95% CI: 1.82, 2.12), and high perceived seriousness of COVID-19 (AOR = 3.21, 95% CI: 2.32, 5.98).

Conclusion: More than half participants were willing to accept COVID-19 vaccine. Thus, awareness creation battles about the efficacy and safety of the COVID-19 vaccine should be provided to the community. Besides, policy-makers, health planners and other stakeholders should encourage COVID-19 vaccine uptake behaviors by providing trusted information.Systematic review and meta-analysis registration: PROSPERO CRD42021264708.

Keywords: AOR, Adjusted odd ratio; Acceptance; CI, Confidence intervals; COVID-19; COVID-19, Coronavirus disease 2019; Ethiopia; PRISMA, Preferred Reporting Items for Systematic review and Meta-analysis; Risk factors; SMP, self-medication practice; Vaccine; WHO, World Health Organization.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interest.

Figures

Fig. 1
Fig. 1
Flow chart of study selection for systematic review and meta-analysis of COVID-19 vaccine acceptance in Ethiopia, 2021.
Fig. 2
Fig. 2
Funnel plot assessed for publication bias in the studies conducted on of COVID-19 vaccine acceptance in Ethiopia, 2021.
Fig. 3
Fig. 3
Forest plot of the pooled proportion of COVID-19 vaccine acceptance in Ethiopia, 2021.
Fig. 4
Fig. 4
Sub-group analysis (by region) of the pooled proportion of COVID-19 vaccine acceptance in Ethiopia, 2021.
Fig. 5
Fig. 5
Sub-group analysis (by study population) of the pooled proportion of COVID-19 vaccine acceptance in Ethiopia, 2021.
Fig. 6
Fig. 6
Sub-group analysis (by data collection method) of the pooled proportion of COVID-19 vaccine acceptance in Ethiopia, 2021.

Similar articles

Cited by

References

    1. Sage W. 2020. WHO SAGE Values Framework for the Allocation and Prioritization of COVID-19 Vaccination.
    1. Dror A.A., Eisenbach N., Taiber S., et al. Vaccine hesitancy: the next challenge in the fight against COVID-19. Eur J Epidemiol. 2020;35(8):775–779. - PMC - PubMed
    1. Shrotri M., Swinnen T., Kampmann B., Parker E.P. An interactive website tracking COVID-19 vaccine development. Lancet Global Health. 2021;9(5):e590–e592. - PMC - PubMed
    1. Hajj Hussein I., Chams N., Chams S., et al. Vaccines through centuries: major cornerstones of global health. Front Public Health. 2015;3:269. - PMC - PubMed
    1. Betsch C., Böhm R., Korn L., Holtmann C. On the benefits of explaining herd immunity in vaccine advocacy. Nat Hum Behav. 2017;1(3):1–6.